AXL Is a Novel Predictive Factor and Therapeutic Target for Radioactive Iodine Refractory Thyroid Ca...
AXL Is a Novel Predictive Factor and Therapeutic Target for Radioactive Iodine Refractory Thyroid Cancer
About this item
Full title
Author / Creator
Collina, Francesca , La Sala, Lucia , Liotti, Federica , Prevete, Nella , La Mantia, Elvira , Chiofalo, Maria Grazia , Aquino, Gabriella , Arenare, Laura , Cantile, Monica , Liguori, Giuseppina , Di Gennaro, Francesca , Pezzullo, Luciano , Losito, Nunzia Simona , Vecchio, Giancarlo , Botti, Gerardo , Melillo, Rosa Marina and Franco, Renato
Publisher
Switzerland: MDPI AG
Journal title
Language
English
Formats
Publication information
Publisher
Switzerland: MDPI AG
Subjects
More information
Scope and Contents
Contents
Papillary thyroid carcinomas (PTCs) have an excellent prognosis, but a fraction of them show aggressive behavior, becoming radioiodine (RAI)-resistant and/or metastatic. AXL (Anexelekto) is a tyrosine kinase receptor regulating viability, invasiveness and chemoresistance in various human cancers, including PTCs. Here, we analyze the role of AXL in...
Alternative Titles
Full title
AXL Is a Novel Predictive Factor and Therapeutic Target for Radioactive Iodine Refractory Thyroid Cancer
Authors, Artists and Contributors
Author / Creator
La Sala, Lucia
Liotti, Federica
Prevete, Nella
La Mantia, Elvira
Chiofalo, Maria Grazia
Aquino, Gabriella
Arenare, Laura
Cantile, Monica
Liguori, Giuseppina
Di Gennaro, Francesca
Pezzullo, Luciano
Losito, Nunzia Simona
Vecchio, Giancarlo
Botti, Gerardo
Melillo, Rosa Marina
Franco, Renato
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6628138
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6628138
Other Identifiers
ISSN
2072-6694
E-ISSN
2072-6694
DOI
10.3390/cancers11060785
